CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-20 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 75,109 | ||
| 2026-01-20 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 53,280 | ||
| 2026-01-12 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,259 | $30.46 | $191K | 321,666 |
| 2026-01-12 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 326,106 |
| 2026-01-12 | Lewis William Chair and CEO | Sale 10b5-1 | −3,974 | $167.73 | $667K | 322,132 |
| 2026-01-12 | Lewis William Chair and CEO | Sale 10b5-1 | −7,176 | $168.63 | $1.2M | 314,956 |
| 2026-01-12 | Lewis William Chair and CEO | Sale 10b5-1 | −6,996 | $169.57 | $1.2M | 307,960 |
| 2026-01-12 | Lewis William Chair and CEO | Sale 10b5-1 | −160 | $170.24 | $27K | 307,800 |
| 2026-01-12 | Lewis William Chair and CEO | Sale 10b5-1 | −297 | $171.31 | $51K | 307,503 |
| 2026-01-12 | Lewis William Chair and CEO | Sale 10b5-1 | −297 | $172.36 | $51K | 307,206 |
| 2026-01-12 | Lewis William Chair and CEO | Sale 10b5-1 | −315 | $174.86 | $55K | 306,891 |
| 2026-01-12 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 81,368 | ||
| 2026-01-12 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 57,720 | ||
| 2026-01-09 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,887 | $186.19 | $351K | 84,907 |
| 2026-01-08 | Smith Michael Alexander Chief Legal Officer | Sale | −1,053 | $174.17 | $183K | 57,037 |
| 2026-01-08 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,660 | $173.87 | $289K | 90,045 |
| 2026-01-08 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −3,251 | $174.17 | $566K | 86,794 |
| 2026-01-08 | Adsett Roger Chief Operating Officer | Sale | −2,059 | $174.17 | $359K | 107,601 |
| 2026-01-08 | Bonstein Sara Chief Financial Officer | Sale | −1,447 | $174.17 | $252K | 80,506 |
| 2026-01-08 | Lewis William Chair and CEO | Sale | −3,223 | $174.17 | $561K | 315,407 |
Page 10 of 23 · 448 trades